These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8787801)

  • 1. Characterization of binding site of uremic toxins on human serum albumin.
    Sakai T; Takadate A; Otagiri M
    Biol Pharm Bull; 1995 Dec; 18(12):1755-61. PubMed ID: 8787801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
    Mabuchi H; Nakahashi H
    Ther Drug Monit; 1988; 10(3):261-4. PubMed ID: 3140432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin.
    Tsutsumi Y; Maruyama T; Takadate A; Goto M; Matsunaga H; Otagiri M
    Pharm Res; 1999 Jun; 16(6):916-23. PubMed ID: 10397614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
    Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
    J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid.
    Tsutsumi Y; Maruyama T; Takadate A; Shimada H; Otagiri M
    Nephron; 2000 May; 85(1):60-4. PubMed ID: 10773757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-bound uremic retention solutes.
    Brunet P; Dou L; Cerini C; Berland Y
    Adv Ren Replace Ther; 2003 Oct; 10(4):310-20. PubMed ID: 14681860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A biophysical insight into structural and functional state of human serum albumin in uremia mimic milieu.
    Zaidi N; Khan RH
    Int J Biol Macromol; 2019 Jun; 131():697-705. PubMed ID: 30904532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
    Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M
    J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced renal clearance of furancarboxylic acid, a major albumin-bound organic acid, in undialyzed uremic patients.
    Sato M; Koyama M; Miyazaki T; Niwa T
    Nephron; 1996; 74(2):419-21. PubMed ID: 8893167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated domains of human serum albumin improves the binding efficiency of uremic toxins: A surface plasmon resonance and computational approach.
    Nerusu A; Vaikuntapu PR; Chinthapalli DK; Podile AR; Subramanyam R
    Int J Biol Macromol; 2020 Jul; 155():1216-1225. PubMed ID: 31734369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Uremic Toxins on the Binding of Aripiprazole to Human Serum Albumin.
    Nishi K; Sakurama K; Watanabe H; Maruyama T; Yamasaki K; Otagiri M
    Biol Pharm Bull; 2021; 44(3):437-441. PubMed ID: 33642552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma concentrations of anionic uremic toxins in hemodialysis patients and their effects on protein binding of pravastatin].
    Ichimura Y; Takamatsu H; Ideuchi H; Oda M; Takeda K; Saitoh H
    Yakugaku Zasshi; 2015; 135(6):821-8. PubMed ID: 26028417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
    Panjehshahin MR; Bowmer CJ; Yates MS
    Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.
    Tsutsumi Y; Deguchi T; Takano M; Takadate A; Lindup WE; Otagiri M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):880-7. PubMed ID: 12388676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-bound uremic solutes: the forgotten toxins.
    Vanholder R; De Smet R; Lameire N
    Kidney Int Suppl; 2001 Feb; 78():S266-70. PubMed ID: 11169024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Plasma Exposures of Conjugated Metabolites of Morinidazole in Renal Failure Patients: A Critical Role of Uremic Toxins.
    Kong F; Pang X; Zhong K; Guo Z; Li X; Zhong D; Chen X
    Drug Metab Dispos; 2017 Jun; 45(6):593-603. PubMed ID: 28314825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.